Let's Talk
Back to Insights

Trade Tracker: Bill Baruch buys more Amgen

Bill Baruch, founder and president at Blue Line Capital, joins CNBC’s “Halftime Report” to detail his latest Amgen purchase. The Investment Committee debate the biotech sector.

Discover Blue Line Capital

Ready to explore how Blue Line Capital can help you achieve your financial goals? Let’s chat! Click the button to get started.

Let’s Chat

Share

Latest Insights

Our team at Blue Line Capital, led by founder Bill Baruch, shares their expertise and unique market perspective.
  • 1 min read

The Committees Energy Strategy

  • 1 min read

Final Trades: Kimberly-Clark, Thermo Fisher, Wabtec and Berkshire Hathaway

  • 1 min read

Is a greater rotation coming? Here’s what experts say

  • 1 min read

Trade Tracker: Bill Baruch buys more Amazon and Uber

View All Insights